Valuation: Dr. Martens plc

Market Cap 629M 841M 753M 695M 1.18B 80.08B 1.19B 8.29B 3.31B 41.91B 3.16B 3.09B 133B P/E 2027 *
13.4x
P/E 2028 * 10.7x
Enterprise Value 827M 1.11B 990M 913M 1.55B 105B 1.57B 10.9B 4.35B 55.09B 4.15B 4.06B 174B EV / Sales 2027 *
1.06x
EV / Sales 2028 * 0.98x
Free-Float
57.55%
Yield 2027 *
3.81%
Yield 2028 * 3.85%
1 day+0.76%
1 week+0.91%
Current month-5.56%
1 month-5.56%
3 months-14.80%
6 months+6.43%
Current year-13.58%
1 week 64.1
Extreme 64.1
69.3
1 month 64.1
Extreme 64.1
72
Current year 59.15
Extreme 59.15
90
1 year 59.15
Extreme 59.15
95.55
3 years 43.02
Extreme 43.02
128
5 years 43.02
Extreme 43.02
448.2
10 years 43.02
Extreme 43.02
521.6
Manager TitleAgeSince
Chief Executive Officer 55 2025-01-05
Director of Finance/CFO 53 2024-05-12
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 53 2020-12-31
Director/Board Member 55 2025-07-09
Director/Board Member 52 2020-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/29/26 Free

Chief Executive Officer

2,732,653 0.2823%
5/29/26 Free

Chief Financial Officer

2,100,151 0.2170%
5/13/26 Buy

Chief Financial Officer

233 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.76%+0.91%-28.04%-44.04% 841M
+3.42%+0.26%-41.21%-60.79% 57.07B
+1.26%+7.37%+0.99%+1.60% 32.47B
+4.88%-0.49%+23.51%+313.42% 19.99B
+2.50%-2.95%-1.29%-13.85% 11.27B
+2.69%-3.53%-16.52%+33.82% 10.96B
+6.17%+14.46%-30.21%-27.00% 6.75B
+25.54%+24.19%+77.42%+74.76% 6.94B
+5.70%-0.86%-16.77%-12.29% 5.94B
+7.91%+8.52%+44.52%-48.73% 4.14B
Average +2.99%+2.79%+1.24%+21.69% 15.64B
Weighted average by Cap. +2.09%+1.60%-10.56%+19.74%

Financials

2027 *2028 *
Net sales 778M 1.04B 932M 860M 1.46B 99.12B 1.48B 10.26B 4.09B 51.87B 3.91B 3.82B 164B 816M 1.09B 978M 902M 1.53B 104B 1.55B 10.76B 4.29B 54.4B 4.1B 4.01B 172B
Net income 48.4M 64.72M 57.97M 53.48M 90.5M 6.16B 91.97M 638M 255M 3.23B 243M 238M 10.22B 59.88M 80.07M 71.72M 66.17M 112M 7.62B 114M 789M 315M 3.99B 300M 294M 12.64B
Net Debt 198M 265M 237M 219M 370M 25.19B 376M 2.61B 1.04B 13.18B 993M 972M 41.76B 170M 227M 204M 188M 318M 21.65B 323M 2.24B 894M 11.33B 853M 835M 35.89B
Projected Income Statement - Annual - Dr. Martens plc
Logo Dr. Martens plc
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company's segments include Europe, the Middle East and Africa (EMEA); Americas; and Asia-Pacific (APAC). Its product segments include boots, shoes, sandals, and bags & other. Its boots offerings include the 1460 8-eye boot, 2976 Chelsea boot, Jadon, Bex and Sinclair. Its shoes offerings include 1461 3-eye shoe and the Adrian tassel loafer, as well as franchises/families such as Buzz and Lowell. Its sandals range includes Blaire and Gryphon silhouettes and also includes the mules range, led by the Zebzag. Its bag range is focused on key silhouettes of leather bags, such as the Kiev backpack, the heart-shaped bag and its weekender bag. This category also includes socks, laces and shoe care. The Company offers its products through direct-to-consumer channel via its ecommerce platforms and its stores, among others.
Employees
2,377
Date Price Change Volume
26-10-30 GBX 66.34 +0.98% 177,926
26-10-29 GBX 65.70 -0.45% 513,018
26-10-28 GBX 66.00 +0.15% 547,887
26-10-27 GBX 65.90 +0.15% 701,417
26-10-26 GBX 65.80 +0.30% 822,469
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Dr. Martens plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
0.6570GBP
Average target price
0.9767GBP
Spread / Average Target
+48.66%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Martens plc
  1. Stock Market
  2. Stocks
  3. DOCS Stock